Scynexis Inc (SCYX)

Currency in USD
0.710
+0.001(+0.13%)
Real-time Data·
SCYX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SCYX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7000.720
52 wk Range
0.6602.210
Key Statistics
Prev. Close
0.709
Open
0.71
Day's Range
0.7-0.72
52 wk Range
0.66-2.21
Volume
78.73K
Average Volume (3m)
163.56K
1-Year Change
-67.1%
Book Value / Share
1.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SCYX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.667
Upside
+557.28%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Scynexis Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Scynexis Inc Company Profile

SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company’s lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Employees
28

Compare SCYX to Peers and Sector

Metrics to compare
SCYX
Peers
Sector
Relationship
P/E Ratio
−1.0x−2.8x−0.5x
PEG Ratio
0.010.010.00
Price/Book
0.5x2.1x2.6x
Price / LTM Sales
10.4x1.4x3.2x
Upside (Analyst Target)
-168.8%42.0%
Fair Value Upside
Unlock16.3%6.6%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.667
(+557.28% Upside)

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-0.11 / -0.21
Revenue / Forecast
257.00K / --
EPS Revisions
Last 90 days

SCYX Income Statement

People Also Watch

265.89
AVAV
-0.93%
18.00
SRPT
+13.71%
0.820
WINT
+0.58%
0.883
PMN
+5.09%
0.3775
VXRT
-5.38%

FAQ

What Stock Exchange Does Scynexis Inc Trade On?

Scynexis Inc is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Scynexis Inc?

The stock symbol for Scynexis Inc is "SCYX."

What Is the Scynexis Inc Market Cap?

As of today, Scynexis Inc market cap is 27.70M.

What Is Scynexis Inc's Earnings Per Share (TTM)?

The Scynexis Inc EPS (TTM) is -0.56.

When Is the Next Scynexis Inc Earnings Date?

Scynexis Inc will release its next earnings report on 17 Aug 2025.

From a Technical Analysis Perspective, Is SCYX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Scynexis Inc Stock Split?

Scynexis Inc has split 1 times.

How Many Employees Does Scynexis Inc Have?

Scynexis Inc has 28 employees.

What is the current trading status of Scynexis Inc (SCYX)?

As of 30 Jul 2025, Scynexis Inc (SCYX) is trading at a price of 0.71, with a previous close of 0.71. The stock has fluctuated within a day range of 0.70 to 0.72, while its 52-week range spans from 0.66 to 2.21.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.